Officials and industry officials said on Wednesday that the Drug Regulatory Authority of Pakistan (DRAP) has agreed to raise the maximum retail price (MRP) of paracetamol as a ‘hardship case’ after various drug manufacturers warned that they would be unable to manufacture the medicine at the current price due to rising raw material costs from China.

“The Drug Pricing Committee (DPC) of the DRAP has recommended some relief to paracetamol manufacturers because prices of its Active Pharmaceutical Ingredient (API) has increased manifolds in the international market,” a DRAP official said on condition of anonymity to The News.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

65 برس سے زائد عمر کے افراد حج کے اہل نہیں ہونگے: سعودی وزارت حج

ریاض: سعودی وزارت حج و عمرہ نے رواں سال حج کےلیےنئے قواعد…

جسٹس عمرعطا بندیال نے بطورچیف جسٹس آف پاکستان حلف اٹھا لیا

حلف برداری کی تقریب ایوان صدر اسلا م آباد میں منعقد کی…

Director of Al Shifa Hospital released from Israeli detention

Mohammad Abu Salmiya, the director of Al Shifa, Gaza’s biggest hospital, was…

Israel will hold Lebanon responsible if ceasefire collapses: Defence Minister

Israeli Defence Minister Israel Katz said on Tuesday that if the ceasefire…